Alvino Maestri

Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Clesrovimab in Infants at Increased Risk For Severe Disease During 2 RSV Seasons: A Randomized Clinical Trial.

Clesrovimab in Infants at Increased Risk For Severe Disease During 2 RSV Seasons: A Randomized Clinical Trial.

Journal: JAMA pediatrics

Published: July 20, 2026

Early Immune Hypoactivation and Persistent Innate Reprogramming Characterize Chronic Chikungunya Disease.

Early Immune Hypoactivation and Persistent Innate Reprogramming Characterize Chronic Chikungunya Disease.

Journal: bioRxiv : the preprint server for biology

Published: July 03, 2026

Identification of a TCR signature in peripheral blood derived CD4+ T cells, associated with chronic chikungunya disease, suggests a conducive, female-biased, background immune profile.

Identification of a TCR signature in peripheral blood derived CD4+ T cells, associated with chronic chikungunya disease, suggests a conducive, female-biased, background immune profile.

Journal: Frontiers in immunology

Published: November 04, 2025

Systems Immunology Approaches to Understanding Immune Responses in Acute Infection of Yellow Fever Patients.

Systems Immunology Approaches to Understanding Immune Responses in Acute Infection of Yellow Fever Patients.

Journal: Journal of medical virology

Published: May 17, 2024

A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen in healthy infants in South Korea (PNEU-PED-KOR).

A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen in healthy infants in South Korea (PNEU-PED-KOR).

Journal: Human vaccines & immunotherapeutics

Published: March 18, 2024

Levels of Angiopoietin 2 Are Predictive for Mortality in Patients Infected With Yellow Fever Virus.

Levels of Angiopoietin 2 Are Predictive for Mortality in Patients Infected With Yellow Fever Virus.

Journal: The Journal of infectious diseases

Published: March 26, 2023

Side-by-side Comparative Study of the Immunogenicity of the Intramuscular and Intradermal Rabies Post-exposure Prophylaxis Regimens in a Cohort of Suspected Rabies Virus Exposed Individuals.

Side-by-side Comparative Study of the Immunogenicity of the Intramuscular and Intradermal Rabies Post-exposure Prophylaxis Regimens in a Cohort of Suspected Rabies Virus Exposed Individuals.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: February 27, 2023

Viral Kinetics in Sylvatic Yellow Fever Cases.

Viral Kinetics in Sylvatic Yellow Fever Cases.

Journal: The Journal of infectious diseases

Published: July 29, 2022

Dissecting drivers of immune activation in chronic HIV-1 infection.

Dissecting drivers of immune activation in chronic HIV-1 infection.

Journal: EBioMedicine

Published: January 06, 2022

Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.

Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.

Journal: Frontiers in immunology

Published: November 18, 2021

Neurological manifestations in people living with HIV/AIDS in the late cART era: a prospective observational study at a tertiary healthcare center in São Paulo, Brazil.

Neurological manifestations in people living with HIV/AIDS in the late cART era: a prospective observational study at a tertiary healthcare center in São Paulo, Brazil.

Journal: HIV research & clinical practice

Published: September 16, 2021

Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial.

Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial.

Journal: The Lancet. Infectious diseases

Published: August 21, 2019

Showing 1-12 of 22

Last Updated: 09/26/2026